The human interleukin-23 ELISA test (IL-23) quantifies human LY-23 in serum, plasma, buffered solution or human cell culture medium.The assay will recognize only natural human LY-23 and human culture media.
The human ELISA test for human interleukin-23 (IL-23) quantifies human L − 23 in serum, plasma, The assay will only recognize natural and recombinant human L-IL-23.Method principle The ELISA (immuno-enzymatic test) solid phase sandwich of human L-IL-23 is designed to measure the amount of the target bound between a pair of matched antibodies.A target specific antibody was pre-selected in the human cell culture media. The samples, standards or controls are then added to these wells and bind to the immobilized antibody (capture).The sandwich is formed by the addition of the second antibody (detector), a substrate solution that reacts with the enzyme-antibodies-target complex to produce a measurable signal.The intensity of this coloured product is directly proportional to the concentration of TP (p) present in the original sample.Strict validation Each batch manufactured from this ELISA kit is tested for quality for criteria such as sensitivity, specificity, The accuracy and consistency of batch to batch.See the product manual for more information on validation.
Recombinant L-IL-23 of eBioscience is produced in cells of bacteria infected with baculovirus as authentic heterodimer of subunits p19 and p40 precursors using a dual promoter expression system. It is distinct from other available forms of protein in that it is expressed as a true heterodimer, as opposed to a single-chain pseudoheterodimer in which the subunits are joined by an artificial binder.
Sensitivity
Sensitivity of the dosage: 4.0 pg/ml.
Measurement range
Dose range: 15.6-2.000 pg/ml.
Duration of dosing
Total duration of dosing: 3 h 45 min.
Reproducibility
Coefficient of variation in intra-dose 5.9%, inter-dose 6.3%.
Technical specifications
| General |
| Brand | Invitrogen |
| Supplier ref. (Fisher Scientific) | 15591507 |
| Specifications |
| Accession number | Q9NPF7 |
| Dose range | 15.6-2.000 pg/ml |
| Sensitivity of the dosage | 4.0 pg/ml |
| Conjugate | Biotin |
| Product type | Kit ELISA |
| Type of sample | Serum, Surnatant, Supernatant |
| Target species | Human |
| For use with (application) | ELISA |
| For use with (equipment) | Colorimetric microplate reader |
| Genetic identification (Enter) | 51561 |
| Gene symbol(s) | IL-23,IL-23A,IL23P19,P19,SGRF |
| Coefficient of inter-dose variation | 6.3% |
| Coefficient of intra-dose variation | 5.9% |
| Contents of kits | 96-well pre-coated plate, Stalion, Sample thinner, Dose buffer concentrate, Biotinylated detection antibody, Wash pad, Chromogen, Stop solution, Adhesive Plate Covers, Adhesive Plate Covers |
| Marker or dye | HRP |
| Quantity | 96 Tests |
| Regulatory status | RUO |
| Synonym | JKA3 induced by T cell activation, SGRF |
| Target | Human |
| Test time | 1 h 20 min |
| Physical characteristics |
| Volume of sample | Plasma, 50 μl; Serum, 50 μl; Supernatant, 50 μl |
| Storage and shipping |
| Storage conditions | 2°C to 8°C |
| Total duration of dosing | 3 h 45 min |
Origin and customs
| Manufacturer ref. | BMS2023-3 |
|---|
| Country of origin | Autriche |
|---|
| HS customs code | 3002 15 00 00 |
|---|
A question or a specific configuration?
Contact us for a quote.